With the publication of the EPA’s hazardous waste pharmaceuticals final rule in February, 2019, aging services providers suddenly found themselves trying to navigate an entirely new regulatory structure. Fortunately, only a small portion of that rule has yet to become enforceable in Pennsylvania. Now a little known set of standards finalized in 2016 by the United States Pharmacopeial Convention (USP), known as USP Chapter 800, has introduced comprehensive and often costly measures designed to promote safe handling of hazardous drugs. This webinar will delve into the requirements of both the EPA rule and USP 800, discuss areas in which the two overlap, and examine the likely enforcement structure of USP 800.
The presenters for this webinar will be Jennifer Hilliard, Esq. and Robert Durkin from Arnall Golden Gregory LLP.
Ms. Hilliard focuses her practice on long-term care and aging services issues generally. She has extensive experience with nursing home regulatory matters, compliance and operations. Additionally, she has significant experience with Federal public policy and government affairs in such related areas as Medicare and Medicaid regulation, home health and hospice regulation, DEA controlled substances regulation, OSHA and other labor and employment issues affecting aging services providers, and federal non-profit tax issues.
Bob Durkin joins AGG as of counsel in the firm’s FDA and Healthcare practices, and is a member of the Dietary Supplements industry team. As a former acting Director and Deputy Director of the Office of Dietary Supplement Programs (ODSP) in the FDA’s Center for Food Safety and Applied Nutrition (CFSAN), he brings a wealth of knowledge and insight to his legal practice.
NHA/PCHA: This program has been approved for Continuing Education for 1.0 total participant hours by NAB/NCERS. Approval# 20210121-1-A62773-DL.
This webinar is free to LeadingAge PA members. Non-members must pay a fee of $70. To receive continuing education credit for LeadingAge PA sponsored webinars, attendees must register under their own name, participate through the link supplied after registering, and complete the evaluation after the webinar.